Richard J. Smith, M.D., director of the Molecular Otolaryngology and Renal Research Laboratories (MORL) at the University of Iowa Carver College of Medicine, will begin the 2014-2015 Flexner Discovery Lecture Series on Thursday, Sept. 11.

Ebola. Chikungunya. Influenza. What’s to be done about these headline-grabbing, debilitating, often lethal viruses?

In some cases, HDL, the "good cholesterol," may not function properly and may actually accelerate atherosclerosis.

It sounds like a potato chip. But CRISPR is actually the acronym for a new genome editing technique that, by many accounts, is accelerating the study of genes and disease.

Reporting last week in the journal Cell, researchers from Oregon Health and Science University, Harvard Medical School and Vanderbilt University describe the first “four-dimensional” picture of a brain receptor that plays a key role in learning and memory.

Vanderbilt University’s P. Jeffrey Conn, Ph.D., has won a Javits Neuroscience Investigator Award from the National Institute of Neurological Disorders and Stroke for discoveries that could lead to new treatments for anxiety, schizophrenia and other brain disorders.